PER 1.41% 7.0¢ percheron therapeutics limited

atl1103 development update, page-49

  1. 2,843 Posts.
    This announcement is exactly what i stated the other day.
    Phase 2 will take at least a year to complete.
    Its mid 2013 before there will be any results for ATL1103 and thats only phase 2.
    This is so far off in the future that on this announcement alone and the time involved i would expect to see significant weakness and a CR urgently needed in the near future as completing Phase 2 is expensive.
    No rush here whatsoever IMO.
    All in my opinion and GL.
    Cheers
    Rob
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.